# Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

> **NCT02639702** · PHASE4 · RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 30 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Clozapine

## Key facts

- **NCT ID:** NCT02639702
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-08
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02639702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02639702, "Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02639702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*